Wockhardt Q4 Results
- BSE: 532300
- NSE: WOCKPHARMA
- ISIN: INE049B01025
- Sector: Biotechnology & Drugs
BSE
1,375.65
-52.35 (-3.67%)
-52.35 (-3.67%)Volume20.72 K
Updated: Fri 24 Jan, 2025 | 15:52:50
NSE
1,376.05-54.05 (-3.78%)
-54.05 (-3.78%)Volume4.76 L
Updated: Fri 24 Jan, 2025 | 15:59:44
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Wockhardt Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 23 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 700.00 | 701.00 | -0.14% | 678.00 | 3.24% |
| Selling/ General/ Admin Expenses Total | 157.00 | 152.00 | 3.29% | 144.00 | 9.03% |
| Depreciation/ Amortization | 58.00 | 55.00 | 5.45% | 56.00 | 3.57% |
| Other Operating Expenses Total | 219.00 | 195.00 | 12.31% | 213.00 | 2.82% |
| Total Operating Expense | 807.00 | 704.00 | 14.63% | 815.00 | -0.98% |
| Operating Income | -107.00 | -3.00 | 3466.67% | -137.00 | -21.90% |
| Net Income Before Taxes | -180.00 | -87.00 | 106.90% | -193.00 | -6.74% |
| Net Income | -169.00 | -83.00 | 103.61% | -207.00 | -18.36% |
| Diluted Normalized EPS | -5.80 | -5.75 | 0.81% | -10.05 | -42.35% |